Benign course in multiple sclerosis: a review

Authors


J. De Keyser, Department of Neurology, University Medical Centre Groningen, Hanzeplein 1, PO Box 30.001, 9700 RB Groningen, The Netherlands
Tel.: +31 50 3612736
Fax: +31 50 3611707
e-mail: j.h.a.de.keyser@neuro.umcg.nl

Abstract

Since the 1950s, it has been recognized that a subgroup of multiple sclerosis (MS) patients exists that shows little or no progression in the severity of the disease over time. This group is referred to as ‘benign’ MS. Although a substantial amount of research in MS indicates a multifactorial background in disease severity, to date it is still difficult to predict whether the course will be benign at onset and it is difficult to find factors that influence the course of the disease over time. Maintaining or restoring neural conduction inside a central nervous system lesion seems to be the essence of staying ‘benign’.

Ancillary